Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentamin PLC Regulatory News (CEY)

Share Price Information for Centamin PLC (CEY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 121.20
Bid: 100.40
Ask: 140.00
Change: 0.00 (0.00%)
Spread: 39.60 (39.442%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 121.20
CEY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

23 Mar 2021 12:29

RNS Number : 2146T
Centamin PLC
23 March 2021
 

 

23 March 2021

 

Centamin plc

("Centamin" or "the Company")

(LSE:CEY, TSX:CEE)

 

 

 

NOTICE OF DIRECTOR DEALING

 

 

In accordance with the requirements of Article 19 of the EU Market Abuse Regulation, Centamin makes the below notification and public disclosure of a transaction by a Director of the Company.

On 23 March 2021, Mark Bankes, Non-Executive Director, purchased 30,000 ordinary shares in the Company at a price of 104.65 pence per share. After settlement of the transaction, Mark will hold a total of 220,000 ordinary shares in the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Bankes

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centamin plc

b)

LEI

LEI 213800PDI9G7OUKLPV84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares

 

ISIN JE00B5TT1872

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

104.65 pence

30,000

 

d)

Aggregated information

-

Aggregated volume

-

Price

 

 

30,000 CEY shares

104.65 pence

e)

Date of the transaction

2021-03-23

f)

Place of the transaction

London Stock Exchange

 

This announcement contains ongoing regulated information.

 

 

FOR MORE INFORMATION: please visit the website www.centamin.com or contact:

 

Centamin plc

Alexandra Barter-Carse, Corporate Communications

+44 (0) 7700 713 738

investors@centamin.je

 

Buchanan

Bobby Morse / Kelsey Traynor

+ 44 (0) 20 7466 5000

centamin@buchanan.uk.com

__________________________________________________________________________________________

Forward-looking Statements

This announcement (including information incorporated by reference) contains "forward-looking statements" and "forward-looking information" under applicable securities laws (collectively, "forward-looking statements"), including statements with respect to future financial or operating performance. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "believes", "expects", "expected", "budgeted", "forecasts" and "anticipates". Although Centamin believes that the expectations reflected in such forward-looking statements are reasonable, Centamin can give no assurance that such expectations will prove to be correct. Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of Centamin about future events and are therefore subject to known and unknown risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, there are a number of factors that could cause actual results, performance, achievements or developments to differ materially from those expressed or implied by such forward-looking statements; general business, economic, competitive, political and social uncertainties; the results of exploration activities and feasibility studies; assumptions in economic evaluations which prove to be inaccurate; currency fluctuations; changes in project parameters; future prices of gold and other metals; possible variations of ore grade or recovery rates; accidents, labour disputes and other risks of the mining industry; climatic conditions; political instability; decisions and regulatory changes enacted by governmental authorities; delays in obtaining approvals or financing or completing development or construction activities; and discovery of archaeological ruins. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information or statements. Forward-looking statements contained herein are made as of the date of this announcement and the Company disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Accordingly, readers should not place undue reliance on forward-looking statements.

LEI: 213800PDI9G7OUKLPV84

Company No: 109180

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAADDAAKFEFA
Date   Source Headline
10th Dec 202012:30 pmRNSDirector Declaration
8th Dec 20207:00 amRNSDirector/PDMR Shareholding
7th Dec 20207:00 amRNSDirector/PDMR Shareholding
2nd Dec 20207:00 amRNSUnlocking Centamin’s Potential – Market Event
2nd Dec 20207:00 amRNSOpen Pit Contract Award
25th Nov 20207:00 amRNSNOTIFICATION OF CAPITAL MARKETS EVENT
20th Nov 20207:11 amRNSNotification of Major Holding(s)
19th Nov 20204:40 pmRNSNotification of Major Holding(s)
18th Nov 20207:00 amRNSDirector Declaration
2nd Nov 20202:30 pmRNSDirector Declaration
29th Oct 20207:00 amRNSAppointment of Joint Corporate Broker
21st Oct 20207:00 amRNSQ3 2020 Report
7th Oct 20207:00 amRNSNOTICE OF DIRECTOR DEALING
6th Oct 20207:00 amRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSSukari Operational Update
2nd Sep 202012:00 pmRNSDirector/PDMR Shareholding
14th Aug 20207:00 amRNSNotice of New Website
4th Aug 20207:01 amRNS2020 Interim Results
4th Aug 20207:00 amRNSDividend Declaration
13th Jul 20207:00 amRNSQ2 2020 Report
7th Jul 20202:26 pmRNSNotification of Major Holding(s)
29th Jun 20202:34 pmRNSResult of 2020 Annual General Meeting
23rd Jun 20207:02 amRNS2019 Sustainability Report
23rd Jun 20207:00 amRNSNOTIFICATION OF MAJOR HOLDINGS
9th Jun 20203:58 pmRNSNotification of Major Holding(s)
8th Jun 20207:00 amRNSDIRECTOR/PDMR SHARE AWARDS
8th Jun 20207:00 amRNSDIRECTOR/PDMR SHARE AWARDS
1st Jun 20207:13 amRNSAppointment of Non-Executive Director
27th May 20207:00 amRNSNotice of AGM & Publication of 2019 Annual Report
18th May 20207:01 amRNSPayments to Governments Report
18th May 20207:00 amRNSAnnual Results for the year ended 31 December 2019
18th May 20207:00 amRNSAnnual Results for the year ended 31 December 2019
11th May 20209:00 amRNSNotification of Full Year 2019 Results
11th May 20207:00 amRNSDirector Declaration
27th Apr 20207:00 amRNSDisclosure of Rights attached to Equity Shares
21st Apr 20207:00 amRNSQuarterly Report and Dividend Declaration
20th Apr 20205:34 pmRNSNOTIFICATION OF MAJOR HOLDINGS
6th Apr 20207:01 amRNSNOTIFICATION OF MAJOR HOLDINGS
6th Apr 20207:00 amRNSDonation towards Egypt’s COVID-19 Relief Efforts
2nd Apr 20207:00 amRNSAppointment of CEO
25th Mar 20207:00 amRNSFCA Results Guidance and COVID-19 Update
24th Mar 20209:14 amRNSNotification of Major Holdings
25th Feb 20203:15 pmRNSForm 8.3 - Centamin PLC
21st Feb 20207:00 amRNSForm 8.3 - Centamin PLC
17th Feb 20207:00 amRNSForm 8.3 - Centamin PLC
7th Feb 20204:29 pmRNSForm 8.3 - Centamin PLC
4th Feb 202010:30 amRNSNotification of Major Holding(s)
30th Jan 20207:00 amRNSQ4 2019 Results
29th Jan 20207:00 amRNSForm 8.3 - Centamin PLC
28th Jan 202012:10 pmRNSNotification of Major Holding(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.